GlassScriptPhysician profile
Juliet Eunhe Chung
NPI 1780842245
$1,589.34
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,369 · 2020: $200 · 2021: $19.96.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $468.89 | 2019-2021 | |
| Allergan, INC. | $408.63 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $238.26 | 2019-2020 | |
| Akorn, INC. | $147.65 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $128.00 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $113.18 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $46.57 | 2019 | |
| Eyevance Pharmaceuticals LLC | $19.36 | 2019 | |
| Dompe US, INC. | $18.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juliet Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.